Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
My Kidney Center, LLC
mi
from
Manhattan, KA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
My Kidney Center, LLC
mi
from
Manhattan, KA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Four Rivers Clinical Research
mi
from
Paducah, KY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Four Rivers Clinical Research
mi
from
Paducah, KY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Crescent City Clinical Res Ctr
mi
from
Metairie, LA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Crescent City Clinical Res Ctr
mi
from
Metairie, LA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Tulane University
mi
from
New Orleans, LA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Tulane University
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Internal Medicine Specialists
mi
from
New Orleans, LA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Internal Medicine Specialists
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Green Clinic LLC
mi
from
Ruston, LA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Green Clinic LLC
mi
from
Ruston, LA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Louisiana State Univ HSC
mi
from
Shreveport, LA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Louisiana State Univ HSC
mi
from
Shreveport, LA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Maine Research Associates
mi
from
Auburn, ME
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Maine Research Associates
mi
from
Auburn, ME
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
MODEL Clinical Research
mi
from
Baltimore, MD
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
MODEL Clinical Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Washington Nephrology Assoc
mi
from
Bethesda, MD
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Washington Nephrology Assoc
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Biolab Research, LLC
mi
from
Rockville, MD
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Biolab Research, LLC
mi
from
Rockville, MD
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Pentucket Medical Assoc
mi
from
Haverhill, MA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Pentucket Medical Assoc
mi
from
Haverhill, MA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
ActivMed Practices and Researc
mi
from
Methuen, MA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
ActivMed Practices and Researc
mi
from
Methuen, MA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
South Shore Nephrology, P.C.
mi
from
Plymouth, MA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
South Shore Nephrology, P.C.
mi
from
Plymouth, MA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Renaissance Renal Research
mi
from
Detroit, MI
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Renaissance Renal Research
mi
from
Detroit, MI
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Hurley Medical Center
mi
from
Flint, MI
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Hurley Medical Center
mi
from
Flint, MI
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Apex Medical Research, MI, Inc.
mi
from
Flint, MI
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Apex Medical Research, MI, Inc.
mi
from
Flint, MI
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Remedica LLC
mi
from
Rochester Hills, MI
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Remedica LLC
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
SouthWest Mississippi Nephrolo
mi
from
Brookhaven, MS
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
SouthWest Mississippi Nephrolo
mi
from
Brookhaven, MS
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Univ of Mississippi Med Ctr,US
mi
from
Jackson, MS
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Univ of Mississippi Med Ctr,US
mi
from
Jackson, MS
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Harry S. Truman Mem Veter Hosp
mi
from
Columbia, MO
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Harry S. Truman Mem Veter Hosp
mi
from
Columbia, MO
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Farmington Research LLC
mi
from
Farmington, MO
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Farmington Research LLC
mi
from
Farmington, MO
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Clinical Research Consultants
mi
from
Kansas City, MO
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Clinical Research Consultants
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Kansas City VA Medical Center
mi
from
Kansas City, MO
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Kansas City VA Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
VA Saint Louis Health Care
mi
from
Saint Louis, MO
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
VA Saint Louis Health Care
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Creighton University Medical Center
mi
from
Omaha, NE
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
NV Kidney Dis Hyper Ctr NKDHC
mi
from
Las Vegas, NV
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
NV Kidney Dis Hyper Ctr NKDHC
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Palm Research Center
mi
from
Las Vegas, NV
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Palm Research Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Sierra Nevada Nephro Consult
mi
from
Reno, NV
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Sierra Nevada Nephro Consult
mi
from
Reno, NV
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Seacoast Kidney and Hypertensi
mi
from
Portsmouth, NH
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Seacoast Kidney and Hypertensi
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Cooper Nephrology
mi
from
Camden, NJ
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Cooper Nephrology
mi
from
Camden, NJ
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Hypertension and Nephrology
mi
from
Eatontown, NJ
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Hypertension and Nephrology
mi
from
Eatontown, NJ
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
University of New Mexico
mi
from
Albuquerque, NM
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Renal Medicine Associates
mi
from
Albuquerque, NM
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Renal Medicine Associates
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Albany Medical College
mi
from
Albany, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Ladan Golestaneh, MD, MS
mi
from
Bronx, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Ladan Golestaneh, MD, MS
mi
from
Bronx, NY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
SUNY Downstate Medical Center
mi
from
Brooklyn, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
SUNY Downstate Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Bentsianov, Brooklyn, NY
mi
from
Brooklyn, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Bentsianov, Brooklyn, NY
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Israel, MD, Brooklyn, NY
mi
from
Brooklyn, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Israel, MD, Brooklyn, NY
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Erie County Medical Center
mi
from
Buffalo, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Erie County Medical Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
North Shore Diabetes
mi
from
New Hyde Park, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
North Shore Diabetes
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
DeFabritus, New York, NY
mi
from
New York, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
DeFabritus, New York, NY
mi
from
New York, NY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
VA NY Harbor Healthcare System
mi
from
New York, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
VA NY Harbor Healthcare System
mi
from
New York, NY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
NYU Langone Medical Center
mi
from
New York, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Ny Clinical Trials
mi
from
New York, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Ny Clinical Trials
mi
from
New York, NY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Kaufman, New York, NY
mi
from
New York, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Kaufman, New York, NY
mi
from
New York, NY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
The Rogosin Institute
mi
from
New York, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
The Rogosin Institute
mi
from
New York, NY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Renal Research Institute
mi
from
New York, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Renal Research Institute
mi
from
New York, NY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Hypertension & Renal Research
mi
from
Orchard Park, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Hypertension & Renal Research
mi
from
Orchard Park, NY
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
Clinical Research Dev Assoc
mi
from
Rosedale, NY
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Clinical Research Dev Assoc
mi
from
Rosedale, NY
Click here to add this to my saved trials